secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2025-11-06T23:59:59+00:00
Accession:  0000313143-25-000074
Event type: earnings
Sentiment:  neutral
Materiality: 0.25
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics announces Q2 FY2026 results; no figures in provided text
--------------------------------------------------------------------

- The company issued a press release on November 6, 2025 for its second quarter ended September 27, 2025.
- First half fiscal 2026 results are also included in the release.
- Specific financial results (revenue, EPS, etc.) are not available in the excerpt provided here.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314325000074/0000313143-25-000074-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314325000074/hae-20251106.htm
  HTML page:      https://secwatch.observer/filing/0000313143-25-000074

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer